Clinical Trials Directory

Trials / Completed

CompletedNCT02879539

Cochlear Implant Low Power Strategy

Clinical Assessment of a Low Power Strategy for Cochlear Implant Recipients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
The Hearing Cooperative Research Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Reducing power consumption in the cochlear implant is crucial to the development of future smaller sound processors. The commercial MP3000 sound coding strategy has been shown to be more efficient in power consumption to the standard ACE strategy. However in order to develop smaller sound processors, further battery life power savings are required. The aim of this study is to evaluate three experimental sets of MP3000 parameter sets, compared against the default ACE program. In the background for each of the four strategies, experimental noise reduction programs (SpatialNR and NR3) will also be in use. In an additional phase of the study, low stimulation rate ACE programs will also be evaluated against the default stimulation rate.

Conditions

Interventions

TypeNameDescription
DEVICEMP3000 sound coding strategy or ACE strategy with lower stimulation

Timeline

Start date
2015-03-31
Primary completion
2017-01-27
Completion
2017-01-27
First posted
2016-08-25
Last updated
2021-07-06

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT02879539. Inclusion in this directory is not an endorsement.